AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode
By A Mystery Man Writer
Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s
A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE (alpha-emitter) in Subjects With Somatostatin Receptor Positive NETs
Anthropic “Claude 3” Models: AI That's Faster, Smarter, and Challenges ChatGPT-4, by AI TutorMaster, Mar, 2024
TechNode
Contemporary Competitive Scenario: Analyzing Roche's Emergent Product, Trontinemab
TechNode
Claude-2: Anthropic's New AI Unveiled, Brings Stronger Reasoning and Coding Skills at a Cheaper Cost : r/ChatGPT
Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode
Beyond Discovery: Leveraging AI To Accelerate Clinical Trials
Two-minute Daily AI Update (Date: 03/05/2024): News from Anthropic, Stability AI, Cloudflare, ChatGPT, Wix, , Groq, and more : r/ArtificialInteligence
Robotic Process Automation (RPA) In Clinical Trials: How Does It Help? - Nividous Intelligent Automation Company
